Logo image of NGMS

NEOGAMES SA (NGMS) Stock Fundamental Analysis

NASDAQ:NGMS - Nasdaq - LU2263803020 - Common Stock - Currency: USD

29.45  +0.02 (+0.07%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NGMS. NGMS was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. NGMS may be in some trouble as it scores bad on both profitability and health. NGMS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NGMS has reported negative net income.
The reported net income has been mixed in the past 5 years: NGMS reported negative net income in multiple years.
NGMS had a positive operating cash flow in each of the past 5 years.
NGMS Yearly Net Income VS EBIT VS OCF VS FCFNGMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

NGMS has a worse Return On Assets (-2.95%) than 75.37% of its industry peers.
NGMS's Return On Equity of -9.62% is in line compared to the rest of the industry. NGMS outperforms 41.79% of its industry peers.
Industry RankSector Rank
ROA -2.95%
ROE -9.62%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.84%
ROE(3y)-6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NGMS Yearly ROA, ROE, ROICNGMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

NGMS does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NGMS Yearly Profit, Operating, Gross MarginsNGMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

NGMS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NGMS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NGMS has more shares outstanding
NGMS has a worse debt/assets ratio than last year.
NGMS Yearly Shares OutstandingNGMS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M
NGMS Yearly Total Debt VS Total AssetsNGMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

NGMS has an Altman-Z score of 2.20. This is not the best score and indicates that NGMS is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NGMS (2.20) is better than 66.42% of its industry peers.
A Debt/Equity ratio of 1.61 is on the high side and indicates that NGMS has dependencies on debt financing.
NGMS has a Debt to Equity ratio of 1.61. This is comparable to the rest of the industry: NGMS outperforms 55.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 2.2
ROIC/WACCN/A
WACC8.07%
NGMS Yearly LT Debt VS Equity VS FCFNGMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 1.10 indicates that NGMS should not have too much problems paying its short term obligations.
NGMS has a Current ratio (1.10) which is in line with its industry peers.
NGMS has a Quick Ratio of 1.10. This is a normal value and indicates that NGMS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NGMS (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
NGMS Yearly Current Assets VS Current LiabilitesNGMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.14% over the past year.
Looking at the last year, NGMS shows a very strong growth in Revenue. The Revenue has grown by 95.92%.
Measured over the past years, NGMS shows a very strong growth in Revenue. The Revenue has been growing by 52.14% on average per year.
EPS 1Y (TTM)32.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
Revenue 1Y (TTM)95.92%
Revenue growth 3Y57.31%
Revenue growth 5Y52.14%
Sales Q2Q%-25.46%

3.2 Future

NGMS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 60.44% yearly.
The Revenue is expected to grow by 13.74% on average over the next years. This is quite good.
EPS Next Y43.33%
EPS Next 2Y60.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.79%
Revenue Next 2Y13.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NGMS Yearly Revenue VS EstimatesNGMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
NGMS Yearly EPS VS EstimatesNGMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NGMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NGMS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NGMS Price Earnings VS Forward Price EarningsNGMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NGMS is valued a bit more expensive than 77.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.56
NGMS Per share dataNGMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

NGMS's earnings are expected to grow with 60.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.44%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NGMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEOGAMES SA

NASDAQ:NGMS (4/23/2024, 8:15:31 PM)

29.45

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-06 2024-03-06/amc
Earnings (Next)05-08 2024-05-08/amc
Inst Owners0.95%
Inst Owner Change-10.83%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap990.40M
Analysts48.89
Price Target30.09 (2.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-145.35%
Min EPS beat(2)-268.15%
Max EPS beat(2)-22.55%
EPS beat(4)1
Avg EPS beat(4)-160.08%
Min EPS beat(4)-434.22%
Max EPS beat(4)84.59%
EPS beat(8)1
Avg EPS beat(8)-315.68%
EPS beat(12)3
Avg EPS beat(12)-187.07%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-23.07%
Min Revenue beat(2)-28.81%
Max Revenue beat(2)-17.33%
Revenue beat(4)0
Avg Revenue beat(4)-18.92%
Min Revenue beat(4)-28.81%
Max Revenue beat(4)-9.94%
Revenue beat(8)0
Avg Revenue beat(8)-26.02%
Revenue beat(12)1
Avg Revenue beat(12)-22.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.43%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-160.87%
EPS NY rev (3m)-160.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.65
P/FCF N/A
P/OCF N/A
P/B 7.34
P/tB N/A
EV/EBITDA 29.56
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.33
BVpS4.01
TBVpS-5.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.95%
ROE -9.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.84%
ROE(3y)-6.24%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 5.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 2.2
F-ScoreN/A
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.08%
EPS Next Y43.33%
EPS Next 2Y60.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)95.92%
Revenue growth 3Y57.31%
Revenue growth 5Y52.14%
Sales Q2Q%-25.46%
Revenue Next Year2.79%
Revenue Next 2Y13.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-192.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year945.51%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y455.87%
FCF growth 3Y77.09%
FCF growth 5YN/A
OCF growth 1Y51.47%
OCF growth 3Y33.31%
OCF growth 5Y60.94%